TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma
Clinical trial NCT05562024 · RECRUITING
Trial details
- NCT number
- NCT05562024
- Sponsor
- PersonGen BioTherapeutics (Suzhou) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-30
- Primary completion
- 2025-12-18
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.